BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35594773)

  • 21.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary
    Ueda S; Hashimoto K; Miyabe S; Hasegawa S; Goto M; Shimizu D; Oh-Iwa I; Shimozato K; Nagao T; Nomoto S
    In Vivo; 2020; 34(5):2353-2361. PubMed ID: 32871760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
    Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
    Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Saliva-based cell-free DNA and cell-free mitochondrial DNA in head and neck cancers have promising screening and early detection role.
    Sayal L; Hamadah O; Almasri A; Idrees M; Thomson P; Kujan O
    J Oral Pathol Med; 2023 Jan; 52(1):29-36. PubMed ID: 36459078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Value of Salivary miRNA in Head and Neck Squamous Cell Cancer: Systematic Review and Meta-Analysis.
    Kang JW; Eun YG; Lee YC
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Cancer: Integration of Studies for Diagnostic and Therapeutic Precision.
    D'Silva NJ; Gutkind JS
    Adv Dent Res; 2019 Nov; 30(2):45-49. PubMed ID: 31633388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma.
    Cao Y; Green K; Quattlebaum S; Milam B; Lu L; Gao D; He H; Li N; Gao L; Hall F; Whinery M; Handley E; Ma Y; Xu T; Jin F; Xiao J; Wei M; Smith D; Bornstein S; Gross N; Pyeon D; Song J; Lu SL
    Clin Epigenetics; 2018; 10():43. PubMed ID: 29636832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
    Antonsson A; Law MH; Neale RE; Coman WB; Pryor DI; ; Porceddu SV; Whiteman DC
    Cancer Causes Control; 2016 Jun; 27(6):809-15. PubMed ID: 27097911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of mutation landscapes of pretreatment versus recurrent squamous cell carcinoma of the oral cavity: The possible mechanism of resistance to standard treatment.
    Payungwong T; Angkulkrerkkrai K; Chaiboonchoe A; Lausoontornsiri W; Jirawatnotai S; Chindavijak S
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2004. PubMed ID: 38477073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The genomic architectures of tumour-adjacent tissues, plasma and saliva reveal evolutionary underpinnings of relapse in head and neck squamous cell carcinoma.
    Wu P; Xie C; Yang L; Liu Y; Zeng J; Li X; Fang X; Fan Y; Zhao S; Kuang N; Xuan T; Xia X; Yi X; Huang Y; Yu Z; Tang Y
    Br J Cancer; 2021 Sep; 125(6):854-864. PubMed ID: 34230611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
    Saba NF; Dinasarapu AR; Magliocca KR; Dwivedi B; Seby S; Qin ZS; Patel M; Griffith CC; Wang X; El-Deiry M; Steuer CE; Kowalski J; Shin DM; Zwick ME; Chen ZG
    PLoS One; 2020; 15(9):e0238497. PubMed ID: 32986729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
    Al-Amri AM; Vatte C; Cyrus C; Chathoth S; Hashim TM; Mohamed YS; Al Ali R; Alsaid A; Al Ali A
    Cancer Biomark; 2016; 16(3):377-83. PubMed ID: 26889984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study.
    Rapado-González Ó; Brea-Iglesias J; Rodríguez-Casanova A; Bao-Caamano A; López-Cedrún JL; Triana-Martínez G; Díaz-Peña R; Santos MA; López-López R; Muinelo-Romay L; Martínez-Fernández M; Díaz-Lagares Á; Suárez-Cunqueiro MM
    Cancer Med; 2023 Mar; 12(6):6615-6622. PubMed ID: 36420687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer.
    Mithani SK; Smith IM; Zhou S; Gray A; Koch WM; Maitra A; Califano JA
    Clin Cancer Res; 2007 Dec; 13(24):7335-40. PubMed ID: 18094415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
    Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
    Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the regulatory interactions between mutated genes and homeobox genes in the head and neck cancer progression.
    Padam KSR; Chakrabarty S; Hunter KD; Radhakrishnan R
    Arch Oral Biol; 2024 Mar; 159():105872. PubMed ID: 38147801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications.
    Osawa Y; Aoyama KI; Hosomichi K; Uchibori M; Tajima A; Kimura M; Ota Y
    Cancer Treat Res Commun; 2021; 29():100456. PubMed ID: 34563788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.